HS-10504

· Jiangsu Hansoh Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HS-10504, covering 2025-09-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ib Study of HS-10504 Combined Therapy in NSCLC [Phase 1]